Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress
Hongjuan Zhao, Yatong Li, Haiyu Shi, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 909-919
Closed Access | Times Cited: 19

Showing 19 citing articles:

Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer
Xiangyi Kong, Yihang Qi, Xiangyu Wang, et al.
Progress in Materials Science (2023) Vol. 134, pp. 101070-101070
Closed Access | Times Cited: 86
Doxorubicin prodrug-based nanomedicines for the treatment of cancer
Haibo Zhao, Jing Yu, Renshuai Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115612-115612
Closed Access | Times Cited: 51
Tumor-microenvironment-activatable organic phototheranostic agents for cancer therapy
Shuang Zeng, Zhihan Guo, Yifu Hao, et al.
Coordination Chemistry Reviews (2024) Vol. 509, pp. 215786-215786
Closed Access | Times Cited: 26
Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review
Renshuai Zhang, Xiaohua Zhao, Ang Jia, et al.
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125993-125993
Closed Access | Times Cited: 30
A Current Perspective on the Potential of Nanomedicine for Anti-Tuberculosis Therapy
Khushboo Borah, Daniel Kim, Pooja Chand, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 2, pp. 100-100
Open Access | Times Cited: 19
Glucose oxidase and metal catalysts combined tumor synergistic therapy: mechanism, advance and nanodelivery system
Yuhan Fu, Jialin Sun, Yanhong Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy
Keze Hong, Jianrong Cao, Weiting Jiang, et al.
Journal of Colloid and Interface Science (2024) Vol. 678, pp. 750-762
Closed Access | Times Cited: 5
A biomimetic spore nanoplatform for boosting chemodynamic therapy and bacteria-mediated antitumor immunity for synergistic cancer treatment
Cuixia Zheng, Lingling Sun, Hongjuan Zhao, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 3, pp. 100912-100912
Open Access | Times Cited: 4
Integrated non-targeted metabolomics and gut microbial systematic analysis the mechanism of anti-tumour activity of Poriae Cutis-derived lanostane triterpenes in vivo
Shuai Yue, Xi Feng, You‐Sheng Cai, et al.
Food Bioscience (2025), pp. 105978-105978
Closed Access
Reprogramming of Glucose Metabolism by Nanocarriers to Improve Cancer Immunotherapy: Recent Advances and Applications
Kehua Jiang, Hongming Liu, Xiaolong Chen, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 4201-4234
Open Access
Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy
Chen‐Wei Jiang, Minglu Tang, Yun Su, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine
Chenglong Kang, Jianwen Wang, Ruotong Li, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 5955-5955
Open Access | Times Cited: 10
Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer
Ruoyi Wang, Xu Huang, Xiaoxi Chen, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 6, pp. 3568-3598
Open Access | Times Cited: 3
A dual-sensitive nanoparticle-mediated deepening synergistic therapy strategy involving DNA damage and ICD stimuli to treat triple-negative breast cancer
Shangui Liu, Xinru Kong, Yuelin Fang, et al.
Biomaterials Science (2023) Vol. 11, Iss. 18, pp. 6325-6341
Closed Access | Times Cited: 9
Enhancing metformin-induced tumor metabolism destruction by glucose oxidase for triple-combination therapy
Rangrang Fan, Linrui Cai, Hao Liu, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 3, pp. 321-334
Open Access | Times Cited: 7
The antitumor effect of diisopropylamine dichloroacetate on non-small cell lung cancer and its influence on the tumor immune microenvironment
Min Wei, Xiaoyan Shen, Ye Liu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity
Mengdi Ma, Yongliang Zhang, Kanyi Pu, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 1
Redox nanotherapeutics: Fundamentals and applications
Chinmaya Mahapatra
Elsevier eBooks (2024), pp. 229-268
Closed Access
Nanomaterials for the Diagnosis and Treatment of Triple‐Negative Breast Cancer
Xuan Sun, Dandan Li, Lv Y, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access
Page 1

Scroll to top